WALTHAM, Mass., Aug. 19, 2026 (GLOBE NEWSWIRE) — Imprivata, a leading provider of access management solutions for healthcare and other mission-critical industries, today announced it was named to the Constellation ShortList^™ for Healthcare IT Security in Q3 2026. The recognition highlights Imprivata’s leadership in helping healthcare organizations enable fast, secure, zero-friction access for all users across all devices, applications, and workflows. Imprivata solutions strengthen cybersecurity, improve operational efficiency, and reduce cost to keep providers focused on patient care.

“Healthcare organizations need security solutions that strengthen cyber resilience without creating barriers for clinicians and other users,” said Fran Rosch, CEO of Imprivata. “This is becoming increasingly important as healthcare expands its use of mobile devices, interconnected medical devices, third parties who need access, and now, the introduction of AI agents into clinical workflow. Being named to the Constellation ShortList for Healthcare IT Security reflects our commitment to helping customers simplify secure access, protect all digital identities, and support transformation with solutions designed specifically for healthcare’s unique and complex challenges.”

As healthcare organizations accelerate digital transformation and AI adoption, they face the growing challenge of strengthening cybersecurity without creating friction for clinicians or disrupting patient care. Imprivata addresses this challenge with a purpose-built platform that secures all user types—clinicians, knowledge workers, privileged admins, third parties, and AI agents—and streamlines access to all devices, applications, and workflows across the healthcare enterprise.

The Imprivata platform delivers:

Fast, secure, passwordless access to shared clinical workstations mobile devices, and connected medical devices
Advanced identity detection and threat monitoring to identify and remediate risk in real time
Agentic AI identity management to support safe and secure AI adoption at scale
Identity verification to enable secure onboarding, helpdesk authentication, self-service credential enrollment, and password reset
Zero-trust privileged access to mitigate internal and third-party threats
Modern biometric patient identity verification and authentication to reduce fraud, eliminate duplicate records, and minimize claims denials
Intelligent patient privacy and drug diversion monitoring to enhance safety, meet regulatory compliance requirements, and reduce risk

“The push for business transformation via digital and AI has never been greater,” said R “Ray” Wang, CEO and founder at Constellation Research. “In the Age of AI, organizations seek to achieve exponential efficiency with their technology investments. The ShortList provides a jump start in their transformation journey.”

Constellation Research advises leaders on leveraging disruptive technologies to achieve business model transformation and streamline business processes. Products and services named to the Constellation ShortList meet the threshold criteria for this category as determined through client inquiries, partner conversations, customer references, vendor selection projects, market share, and internal research. The portfolio is updated at least once per year as the analyst team deems necessary based on market conditions.

For more information on Constellation, visit www.constellationr.com/research/shortlist/vendor-resources.

About Imprivata
Imprivata delivers simple and secure access management solutions for healthcare and other mission-critical industries to ensure every second of crucial work is both frictionless and secure. Imprivata’s platform of innovative, interoperable access management and privileged access security solutions enable organizations to fully manage and secure all enterprise and third-party identities to facilitate seamless user access, protect against internal and external security threats, and reduce total cost of ownership. For more information, visit www.imprivata.com.

Disclaimer
Constellation Research does not endorse any solution or service named in its research.

Media Contact
press@imprivata.com